What’s the Link Between Collagen and Breast Cancer?
Do collagen supplements increase the risk of breast cancer?
It is a question that comes up with increasing frequency as collagen supplements have become more mainstream. The concern is understandable — collagen plays a significant role in the structure of breast tissue, and research into the relationship between collagen and breast cancer is ongoing. But the question of whether collagen supplements specifically increase breast cancer risk is a different question entirely, and one the evidence answers clearly.
Understanding why the question arises
Collagen is a key structural component of the extracellular matrix (ECM) — the network of proteins and other molecules that surrounds and supports cells throughout the body. The ECM plays a role in regulating how cells grow, divide and migrate. In cancer research, the ECM has been studied extensively because its structure can influence how tumour cells behave.
Some studies have found that a denser ECM, with higher concentrations of certain collagen types, can create an environment that facilitates tumour growth and the migration of cancer cells to other tissues. In particular, elevated levels of Type I and Type IV collagen in breast tissue have been associated with more aggressive breast cancers and higher metastatic potential.
This is important cancer research. But it is research about collagen produced by the body's own cells within tumour tissue — not about collagen consumed as a supplement.
Why supplemental collagen is different from ECM collagen
When you take a hydrolysed marine collagen supplement, you are consuming collagen peptides — short chains of amino acids produced by enzymatically breaking down fish collagen. These peptides are absorbed through the digestive system, enter the bloodstream and reach tissues throughout the body where they stimulate fibroblasts to increase their own collagen synthesis.
The collagen that accumulates in tumour ECM is produced locally by cancer-associated fibroblasts and other cells in the tumour microenvironment. It is a different biological process, in a different location, driven by different cellular signals. Consuming collagen peptides orally does not selectively increase collagen production in tumour tissue, and there is no established mechanism by which it would do so.
The research that identifies collagen density as a factor in breast cancer progression is not studying people who take collagen supplements. It is studying the tumour microenvironment itself. These findings cannot be extrapolated to supplement use.
What the research actually shows about collagen supplements and cancer
As of the current evidence base, no peer-reviewed clinical study has demonstrated that collagen supplementation increases the risk of developing breast cancer or accelerates its progression in people who have it. The concern is theoretical rather than clinical, and the theoretical mechanism is not supported by what we know about how hydrolysed collagen peptides behave in the body.
This is consistent with the broader picture of collagen supplement safety. Decades of clinical research across thousands of participants has not identified cancer risk as an adverse effect of collagen supplementation. Collagen is a naturally occurring protein that the body produces and uses continuously. Supplementing with hydrolysed peptides from fish simply provides additional amino acid building blocks for the body's own collagen synthesis processes.
Should breast cancer patients or survivors take collagen supplements?
This is an individual decision that should be made in conversation with your oncologist or GP. There is no clinical evidence that collagen supplements are harmful for breast cancer patients or survivors, but every cancer diagnosis and treatment plan is different. Your healthcare team is best placed to give personalised advice based on your specific situation, medications and treatment history.
Some points worth raising with your doctor:
- Whether any supplements you are considering interact with your current medications or treatments
- Whether the additional nutrients in your collagen supplement, such as Vitamin C or B vitamins, are appropriate for your situation
- Whether there are any contraindications specific to your diagnosis or treatment protocol
Choosing a high-quality collagen supplement
For anyone considering collagen supplementation, quality is the most important factor. Lower-quality products can contain contaminants from intensive farming practices, including heavy metals, antibiotics and growth hormones. Daily use of a contaminated product over months represents a genuine concern that is separate from the cancer question entirely.
Kollo uses Naticol® marine collagen — a patented ingredient sourced from sustainably certified fisheries, produced through clean enzymatic hydrolysis with no harsh chemicals, and tested for over 250 potentially harmful substances under Informed Choice certification. Every batch is independently verified before release.
You can read more about what to look for in a safe, high-quality supplement in our complete guide to collagen safety.
The broader picture of collagen and women's health
For women who want to understand how collagen fits into a wider supplement routine, our complete guide to liquid marine collagen covers the full evidence base for skin, hair, joints and bone health. Our complete guide to menopause supplements addresses the specific collagen and hormonal changes of perimenopause and menopause. And our guide to the best supplements for women over 40 brings everything together in one practical overview.
If you have specific questions about Kollo and whether it is right for your circumstances, our team can be reached through the Contact page.
Kollo Health was co-founded by Jenni Falconer - TV presenter, Smooth Radio breakfast host, ten-time London Marathon runner and host of the RunPod podcast. Read her story and why she created Kollo.
